Real time PCR for rapid determination of susceptibility of adenovirus to antiviral drugs

Journal of Virological Methods

Volumn 164, Issue 1-2, 2010, Pages 30-34

  Gainotti, Rosana ^a   Ricarte, Carmen ^a   Ebekian, Beatriz ^a   Videla, Cristina ^a   Carballal, Guadalupe ^a   Damonte, Elsa B ^b   Echavarría, Marcela ^a  

^a CEMIC   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Adenovirus; Antiviral drug; Real time PCR; Stavudine

Indexed keywords

STAVUDINE;

ANTIVIRAL ACTIVITY; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CELL VIABILITY; CYTOTOXICITY; DRUG DETERMINATION; HUMAN; HUMAN ADENOVIRUS; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; VIRUS DETECTION; VIRUS LOAD; VIRUS REPLICATION;

ADENOVIRUSES, HUMAN; ANTIVIRAL AGENTS; CAPSID PROTEINS; CELL LINE; DNA PRIMERS; HUMANS; MICROBIAL SENSITIVITY TESTS; PLAQUE ASSAY; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; STAVUDINE; TIME FACTORS;

ADENOVIRIDAE; HUMAN ADENOVIRUS;

EID: 77249124267     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.11.020     Document Type: Article

References (37)

1. Arav-Boger R., Echavarria M., Forman M., Charache P., and Persaud D. Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient. Pediatr. Infect. Dis. J. 19 (2000) 1097-1100
2. Arnold D., Di Biase A.M., Marchetti M., Pietrantoni A., Valenti P., Seganti L., and Superti F. Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection. Antiviral Res. 53 (2002) 153-158
3. Baba M., Mori S., Shigeta S., and de Clreq E. Selective inhibitory effect of (s)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2′-nor cyclic GMP on adenovirus replication in vitro. Antimicrob. Agents Chemother. 31 (1987) 337-339
4. Bordigoni P., Carret A.S., Venard V., Witz F., and Le F.A. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 32 (2001) 1290-1297
5. Cao W., Baniecki M.l., McGrath W.J., Bao C., Deming C.B., Rade J.J., Lowenstein C.J., and Mangel W.J. Nitric oxide inhibits the adenovirus proteinase in vitro and viral infectivity in vivo. FASEB J. 17 (2003) 2345-2346
6. Chiang L.C., Cheng H.Y., Liu M.C., Chiang W., and Lin C.C. In vitro anti-herpes simplex viruses and anti-adenoviruses activity of twelve traditionally used medicinal plants in Taiwan. Biol. Pharm. Bull. 26 (2003) 1600-1604
7. Chung Y.S., Kim M.K., Lee W.J., and Kang C. Silencing E1A mRNA by RNA interference inhibits adenovirus replication. Arch. Virol. 152 (2007) 1305-1314
8. Claas E.C., Schilham M.W., de Brouwer C.S., Hubacek P., Echavarria M., Lankester A.C., van Tol M.J., and Kroes A.C. Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J. Clin. Microbiol. 43 (2005) 1738-1744
9. Das A., Trousdale M.D., Ren S., and Lien E.J. Inhibition of herpessimplex virus type 1 and adenovirus type 5 by heterocyclic Schiff bases of aminohydroxyguanidine tosylate. Antiviral Res. 44 (1999) 201-208
10. De Clercq E. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin. Microbiol. Rev. 16 (2003) 569-596
11. Echavarria M., Forman M., Ticehurst J., Dumler J.S., and Charache P. PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J. Clin. Microbiol. 36 (1998) 3323-3326
12. Gordon Y.J., Romanowski E., Araullo-Cruz T., Seaberg L., Erzurum S., Tolman R., and De Clercq E. inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2′-nor cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro. Antiviral Res. 16 (1991) 11-16
13. Hale G.A., Heslop H.E., Krance R.A., Brenner M.A., Jayawardene D., Srivastava D.K., and Patrick C.C. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant. 23 (1999) 277-282
14. Hippenmeyer P.J., Ruminski P.G., Rico J.G., Lu H.S., and Griggs D.W. Adenovirus inhibition by peptidomimetic integrin antgonists. Antiviral Res. 55 (2002) 169-178
15. Hoffman J.A., Shah A.J., Ross L.A., and Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 7 (2001) 388-394
16. Horne W.S., Wiethoff C.M., Cui C., Wilcoxen K.M., Amorin M., Ghadiri M.R., and Nemerow G.R. Antiviral cyclic d,l-alpha-peptides: targeting a general biochemical pathway in virus infections. Bioorg. Med. Chem. 13 (2005) 5145-5153
17. Jones M.S., Harrach B., Ganac R.D., Gozum M.M., De la Cruz W.P., Riedel B., Pan C., Delwart E., and Schnurr D. New adenovirus species found in a patient presenting with gastroenteritis. J. Virol. 81 (2007) 5978-5984
18. Kodama E., Shigeta S., Suzuki T., and de Clercq E. Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method. Antiviral Res. 31 (1996) 159-164
19. Kruppenbacher J.P., Klass R., and Eggers H.J. A rapid and reliable assay for testing acyclovir sensitivity of clinical herpes simplex virus isolates independent of virus dose and reading time. Antiviral Res. 23 (1994) 11-22
20. Lewis P.F., Schmidt M.A., Lu X., Erdman D.D., Campbell M., Thomas A., Cieslak P.R., Grenz L.D., Tsaknardis L., Gleaves C., Kendall B., and Gilbert D. A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14. J. Infect. Dis. 199 10 (2009) 1427-1434
21. Mangel W.F., Baniecki M.L., and McGrath W.J. Specific interactions of the adenovirus proteinase with the viral DNA, an 11-amino-acid viral peptide, and the cellular protein actin. Cell. Mol. Life Sci. 60 (2003) 2347-2355
22. Morfin F., Dupuis-Girod S., Mundweiler S., Falcon D., Carrington D., Sedlacek P., Bierings M., Cetkovsky P., Kroes A.C., van Tol M.J., and Thouvenot D. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antiviral Ther. 10 (2005) 225-229
23. Morfin F., Dupuis-Girod S., Frobert E., Mundweiler S., Carrington D., Sedlacek P., Bierings M., Cetkovsky P., Kroes A.C., van Tol M.J., and Thouvenot D. Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone. Antiviral Ther. 14 1 (2009) 55-61
24. Naesens L., Lenaerts L., Andrei G., Snoeck R., Van Beers D., Holy A., Balzarini J., and De Clerq E. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob. Agents Chemother. 49 (2005) 1010-1016
25. Paolucci S., Baldanti F., Maga G., Cancio R., Zazzi M., Zavattoni M., Chiesa A., Spadari S., and Gerna G. Gln145Met/Leu changes in human immunodeficiency virus type 1 reversa transcriptase confer resistance to nucleoside and nonnucleoside analogs and impair virus replication. Antimicrob. Agents Chemother. 48 (2004) 4611-4617
26. Rice W.G., Baker D.C., Schaeffer C.A., Graham L., Bu M., Terpening S., Clanton D., Schultz R., Bader J.P., Buckheit Jr. R.W., Field L., Singh P.K., and Turpin J.A. Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins. Antimicrob. Agents Chemother. 41 (1997) 417-426
27. Stock R., Harste G., Madisch I., and Heim A. A rapid quantitative PCR-based assay for testing antiviral agents against human adenoviruses demonstrates type specific differences in ribavirin activity. Antiviral Res. 72 (2006) 34-41
28. Stranska R., van Loon A.M., Polman M., and Schuurman R. Application of real time PCR for determination of antiviral drug susceptibility of herpes simplex virus. Antimicrob. Agents Chemother. 46 (2002) 2943-2947
29. Talarico L.B., and Damonte E.B. Interference in dengue virus adsorption and uncoating by carrageenans. Virology 363 (2007) 473-485
30. Tate J.E., Bunning M.L., Lott L., Lu X., Su J., Metzgar D., Brosch L., Panozzo C.A., Marconi V.C., Faix D.J., Prill M., Johnson B., Erdman D.D., Fonseca V., Anderson L.J., and Widdowson M.A. Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. J. Infect. Dis. 15 199 10 (2009) 1419-1426
31. Uchio E., Fuchigami A., Kadonosono K., Hayashi A., Ishiko H., Aoki K., and Ohno S. Anti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitis. Graefe's Arch. Clin. Exp. Ophthalmol. 245 (2007) 1319-1325
32. Uckun F.M., Pendergrass S., Qazi S., Samuel P., and Venkatachalam T.K. Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus. Eur. J. Med. Chem. 39 (2004) 225-234
33. Venard V., Carret A., Corsaro D., Bordigoni P., and Le Faou A. Genotyping of adenoviruses isolated in an outbreak in a bone marrow transplant unit shows that diverse strains are involved. J. Hosp. Infect. 44 (2000) 71-74
34. Wasserman R., August C.S., and Plotkin S.A. Viral infections in pediatric bone marrow transplant patients. Pediatr. Infect. Dis. J. 7 (1988) 109-115
35. Whitby K., Pierson T.C., Geiss B., Lane K., Engle M., Zhou Y., Doms R.W., and Diamond M.S. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J. Virol. 79 (2005) 8698-8706
36. Wildner O., Hoffmann D., Jogler C., and Uberla K. Comparison of HSV-1 thymidine kinase-dependent and independent inhibition of replication-competent adenoviral vectors by a panel of drugs. Cancer Gene Ther. 10 (2003) 791-802
37. Zarubaev V.V., Slita A.V., Krivitskaya V.Z., Sirotkin A.K., Kovalenko A.L., and Chatterjee N.K. Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro. Antiviral Res. 58 (2003) 131-137